Life Science in the News
Harper Government Invests in Personalized Medicine The Harper Government announced an important investment that will help Canadians in getting more effective treatments. Supreme Court limits Health Canada ability to Disclose Commercially Sensitive Information
The Supreme Court of Canada released a decision that limits Health Canada's ability to disclose an innovator's commercially sensitive pharmaceutical product information to competitors. Benefit of red wine chemical gets 2nd look. "It has potential as a therapy for diverse diseases such as Type 2 diabetes, Alzheimer's disease, and heart disease," said Dr. Jay Chung, Chief of the National Heart, Lung and Blood Institute's laboratory of obesity and aging research. Canada regulatory model not quite perfect, but getting closer. Canada is at the leading edge of trying to work around the inflexibilities in regulations, citizen perceptions and industry by developing a national co-existence policy. Stem cell treatment shows efficacy in type 1 diabetes Patients with moderate to severe type 1 diabetes showed improvements in fasting C-peptide levels and significant reductions in HbA1C rates and insulin doses 12 and 24 weeks after treatment with cord blood stem cells, researchers reported in BMC Medicine. Bill Gates: Countries must embrace high-tech agriculture "Given the central role that food plays in human welfare and national stability, it is shocking -- not to mention short-sighted and potentially dangerous -- how little money is spent on agricultural research," -Bill Gates
| 
